BAD contributes to RAF-mediated proliferation and cooperates with B-RAF-V600E in cancer signaling

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• BAD (Bcl-2 antagonist of cell death) is a proapoptotic protein.
• BAD's function is regulated by phosphorylation.
• The role of specific phosphorylation sites on BAD requires further investigation.

Purpose of the Study:

• To investigate the role of newly identified phosphorylation sites on BAD-mediated apoptosis.
• To elucidate the kinases responsible for BAD phosphorylation.
• To determine the role of BAD phosphorylation in cancer cell proliferation.

Main Methods:

• Site-directed mutagenesis to replace serine residues with alanine.
• Analysis of cell death and proliferation assays.
• Co-expression of BAD with survival kinases (RAF, PAK1) and oncogenic B-RAF-V600E.

Main Results:

• Phosphorylation of BAD at serines 124 and 134 has an antiapoptotic effect; alanine substitution enhances cell death.
• RAF kinases and PAK1 phosphorylate BAD at serine 134.
• Wild-type BAD with survival kinases promotes proliferation, but serine 134 alanine substitution abolishes this.
• BAD serine 134 phosphorylation is critical for proliferation in B-RAF-V600E tumor cells.

Conclusions:

• BAD serine 134 phosphorylation by RAF kinases plays an antiapoptotic role.
• This phosphorylation is crucial for cancer cell proliferation and survival signaling.
• Findings offer new insights into BAD regulation and its role in cancer.